AGL 38.99 Increased By ▲ 0.97 (2.55%)
AIRLINK 207.00 Increased By ▲ 9.64 (4.88%)
BOP 9.64 Increased By ▲ 0.10 (1.05%)
CNERGY 6.04 Increased By ▲ 0.13 (2.2%)
DCL 8.95 Increased By ▲ 0.13 (1.47%)
DFML 37.10 Increased By ▲ 1.36 (3.81%)
DGKC 96.80 Decreased By ▼ -0.06 (-0.06%)
FCCL 35.50 Increased By ▲ 0.25 (0.71%)
FFBL 88.94 Increased By ▲ 6.64 (8.07%)
FFL 13.48 Increased By ▲ 0.31 (2.35%)
HUBC 127.49 Decreased By ▼ -0.06 (-0.05%)
HUMNL 13.84 Increased By ▲ 0.34 (2.52%)
KEL 5.41 Increased By ▲ 0.09 (1.69%)
KOSM 7.09 Increased By ▲ 0.09 (1.29%)
MLCF 45.00 Increased By ▲ 0.30 (0.67%)
NBP 60.84 Decreased By ▼ -0.58 (-0.94%)
OGDC 217.15 Increased By ▲ 2.48 (1.16%)
PAEL 40.85 Increased By ▲ 2.06 (5.31%)
PIBTL 8.45 Increased By ▲ 0.20 (2.42%)
PPL 194.35 Increased By ▲ 1.27 (0.66%)
PRL 39.23 Increased By ▲ 0.57 (1.47%)
PTC 26.75 Increased By ▲ 0.95 (3.68%)
SEARL 107.94 Increased By ▲ 4.34 (4.19%)
TELE 8.53 Increased By ▲ 0.23 (2.77%)
TOMCL 35.67 Increased By ▲ 0.67 (1.91%)
TPLP 13.50 Increased By ▲ 0.20 (1.5%)
TREET 23.25 Increased By ▲ 1.09 (4.92%)
TRG 61.15 Increased By ▲ 5.56 (10%)
UNITY 33.00 Increased By ▲ 0.03 (0.09%)
WTL 1.69 Increased By ▲ 0.09 (5.63%)
BR100 11,931 Increased By 204.9 (1.75%)
BR30 36,892 Increased By 515.2 (1.42%)
KSE100 111,842 Increased By 2328.5 (2.13%)
KSE30 35,234 Increased By 720.4 (2.09%)

With the reference to SRO 412/2014 by Drug Regulatory Authority; Aamir Iqbal, Senior Vice Chairman of the Federation of Pakistan Chamber of Commerce and Industry Committee on Health Care, humility appealed Prime Minister of Pakistan, Mian Mohammad Nawaz Sharif, Finance Minister Ishaq Dar, Minister National Health Services and application of regulatory and communicated to Ms Tarar Saira Afzal to intervene directly in the case about the ban on the sale of Skin care products, herbal, traditional, Chinese, and various food supplements, imported medicines.
He raised the issue that due to such steps may result in the ill-treatment of users and millions of patients may affect the trafficking, parallel trade import and ESP, spurious and fake products will be encouraged. According to international practice and international custom tariffs and import policy under the category of cosmetic products already have been classified.
Human resources and manpower, and the ability of pharmaceutical registration DRA Pharma importers paid a license fee, and they still have the board's agenda, nor do they consider Registration date for the ESP biological and Research Thousands of products, are pending applications are pending in drap. -PR

Copyright Business Recorder, 2015

Comments

Comments are closed.